CAS RN: 564-25-0
Doxycycline
Product Availability
Choose a grade to view its available package options.
3 package records 3 with current stock 1 grade group
Grade
Moligand™, ≥97% (3)
In stock only
Batch No. Package Availability Inquiry
Batchno.20260502
100mg
In stock
Inquiry
Batchno.20250121
20mg
In stock
Inquiry
Batchno.20251029
500mg
In stock
Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 564-25-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
564-25-0 / 4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-1,3,12-trioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
Standard CAS: 564-25-0
Multi CAS: Yes
Basic Information
copy
CAS
564-25-0 copy
Multi CAS
Yes copy
Molecular Formula
C22H24N2O8 copy
Molecular Weight
444.400000 copy
Exact Mass
444.153266 copy
InChI
InChI=1S/C22H24N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-7,10,13-15,17,25-27,32H,1-3H3,(H2,23,31) copy
InChIKey
ZOSHTZVEWUAHLQ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
32 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.45 copy
Rotatable bonds
2 copy
H-bond acceptors
9 copy
H-bond donors
5 copy
Molar refractivity
109.19 copy
TPSA
178.46 copy
LogP / Solubility
WLOGP
-1.13 copy
MLOGP
-0.97 copy
XLogP3
-0.9 copy
Consensus LogP
-1 copy
Log S (ESOL)
-1.89 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-2.39 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-1.85 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
Yes copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-6.23 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
No copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
6.5 copy